OxyChip Implantation and Subsequent Electron Paramagnetic Resonance Oximetry in Human Tumors Is Safe and Feasible: First Experience in 24 Patients

Introduction: Tumor hypoxia confers both a poor prognosis and increased resistance to oncologic therapies, and therefore, hypoxia modification with reliable oxygen profiling during anticancer treatment is desirable. The OxyChip is an implantable oxygen sensor that can detect tumor oxygen levels usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaner, Philip E., Pettus, Jason R., Flood, Ann Barry, Williams, Benjamin B., Jarvis, Lesley A., Chen, Eunice Y., Pastel, David A., Zuurbier, Rebecca A., diFlorio-Alexander, Roberta M., Swartz, Harold M., Kuppusamy, Periannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653093/
https://www.ncbi.nlm.nih.gov/pubmed/33194670
http://dx.doi.org/10.3389/fonc.2020.572060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653093/
https://www.ncbi.nlm.nih.gov/pubmed/33194670
http://dx.doi.org/10.3389/fonc.2020.572060

Ejemplares similares